Quince Therapeutics, Inc. (IRLA)

CIK 1662774 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Quince Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 21, 20261440001628280-26-066751
Oct 19, 20268-K0001193125-26-424731
Oct 19, 202630001233539-26-000003
Oct 19, 202630002159117-26-000002
Oct 19, 202630001662170-26-000002
Oct 19, 202630001930805-26-000004
Oct 19, 202630002159407-26-000002
Oct 19, 202630002159394-26-000002
Oct 14, 2026SCHEDULE 13G0001104659-26-115859
Oct 14, 2026SCHEDULE 13G0001193125-26-421651
Oct 9, 20268-K0001193125-26-418538
Oct 8, 2026S-80001193125-26-418091
Oct 6, 20268-K0001193125-26-415730
Oct 2, 20268-K0001193125-26-411260
Oct 2, 2026DEFA14A0001193125-26-411262
Sep 14, 20268-K0001193125-26-390652
Sep 4, 20268-K0001193125-26-382838
Aug 27, 20268-K0001193125-26-371389
Aug 25, 2026DEF 14A0001193125-26-364220
Aug 24, 2026EFFECT9999999995-26-002741
Aug 17, 20268-K0001193125-26-353141
Aug 14, 202610-Q0001193125-26-352201
Aug 14, 2026SCHEDULE 13G0001193125-26-352966
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097291
Aug 14, 20268-K0001193125-26-350568